Paria Zarghamravanbakhsh, MD
Internal Medicine · Concord
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 3 carriers
- Offices
- 2
- Since medical school
- 16 years
- Graduated 2010
Offices
2 locations · Jiva Health Inc · 46 clinicians in this group
Hospitals listed: Contra Costa Regional Medical Center · Northbay Medical Center. That is not proof they admit you there this week.
Plans that list them
14 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Zarghamravanbakhsh’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A167384 · Current
Licensed to practise in California · since 2019 · expires 2027-12-31 · Zanjan University of Medical Sciences and Health Sciences.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Endocrinology, Diabetes and Metabolism
- American Board of Internal Medicine - Internal Medicine
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Contra Costa Regional Medical CenterMartinez, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Contra Costa Health ServicesPatients rate it 3 of 5 · 73% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.167, Oct 2024 – Sep 2025
- Northbay Medical CenterFairfield, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Northbay Healthcare, which runs 2 hospitalsPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.6 (11 to 18.8) · 166 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Contra Costa Regional Medical Center
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 1 better, 4 the same, 1 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.167 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.99 (0 to 2.04) · 188 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.08 (0.63 to 1.53) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.2 · 44 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.8 · 111 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.4 · 114 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.3 · 27 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 321 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.44) · 1,181 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.47) · 1,198 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.2 (0.67 to 5.72) · 216 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 71 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.5 (0.82 to 4.18) · 195 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.36 (1.01 to 19.71) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.88 (0.69 to 9.08) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.07 (0.55 to 3.58) · 67 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.93 (0 to 2.03) · 981 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.948 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 2.027 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.3 · 101 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 52.2 · 126 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -53.6 · 112 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 87 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.7 to 8.6) · 95 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (8.8 to 17.8) · 95 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 35 cases | None | Jul 2023 – Jun 2025 |
What patients said (521 patients answered, 10% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 79% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 66% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 78% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 45% |
| "YES", patients would definitely recommend the hospital | 73% |
| Staff "always" explained possible side effects | 54% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Northbay Medical Center
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.6 (11 to 18.8) · 166 cases | Worse | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.08 (0.1 to 2.06) · 1,001 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.04 (0.7 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 180.67 (132.84 to 228.51) · 88 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.7 · 31 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 171 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13 · 180 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.4 · 338 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.7 · 552 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.6 · 238 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 2,034 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,261 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.42) · 6,385 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.02 (1.87 to 6.16) · 1,179 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.89 (0.26 to 3.51) · 280 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.02 (0.51 to 3.54) · 1,156 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 12.55 (4.71 to 20.39) · 284 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (1.99 to 9.92) · 276 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.96 (0.48 to 3.43) · 256 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.34 (0 to 1) · 4,549 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 25 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.663 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.985 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.763 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.923 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.6 · 197 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 420 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 0.7 · 197 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 32.6 · 439 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25 · 627 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.8 · 560 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.7 to 7.9) · 166 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.6 · 25 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.9 · 210 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.1 (10.5 to 19) · 196 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 250 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,123 patients answered, 20% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$7,898
Medicare paid this office $7,898 for 36 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 22 | $1,598 | $59 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 13 | $733 | $52 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 13 | $674 | $48 |
Who their Medicare patients are
36 Original Medicare patients in 2024. Average age 68 · Women 64% · Also on Medicaid 53% · Health risk score 1.77. Above the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Diabetes 75% · Chronic kidney disease 44% · Depression 33% · Coronary heart disease 31%.
The office billed $19,627, Medicare allowed $9,924 and paid $7,898; for 348 services of 12 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 36 | 348 | 68 | 1.77 | $19,627 | $7,898 |
| 2023 | 12 | 233 | 72 | 2.25 | $7,401 | $2,906 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
Drugs they prescribed that Part D paid
$491,026
Pharmacies billed $491,026 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 809) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
236 generic and 509 brand-name prescriptions · $491,026 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Tymlos | 50 | $129,689 | $2,594 |
| Trulicity | 61 | $82,485 | $1,352 |
| Ozempic | 62 | $77,049 | $1,243 |
| Jardiance | 40 | $50,056 | $1,251 |
| Mounjaro | 23 | $24,627 | $1,071 |
See all 17 drugs
| Tymlos | 50 | $129,689 | $2,594 |
| Trulicity | 61 | $82,485 | $1,352 |
| Ozempic | 62 | $77,049 | $1,243 |
| Jardiance | 40 | $50,056 | $1,251 |
| Mounjaro | 23 | $24,627 | $1,071 |
| Tresiba Flextouch U-100 | 16 | $9,564 | $598 |
| Lantus Solostar | 60 | $7,271 | $121 |
| Basaglar Kwikpen U-100 | 13 | $4,533 | $349 |
| Synthroid | 52 | $3,989 | $77 |
| Humalog Kwikpen U-100 | 13 | $1,913 | $147 |
| Ultra-Fine Short Pen Needle | 26 | $1,651 | $64 |
| Levothyroxine | 72 | $843 | $12 |
| Nano 2nd Gen Pen Needle | 13 | $776 | $60 |
| Alendronate | 34 | $325 | $10 |
| Metformin | 58 | $307 | $5 |
| Methimazole | 14 | $281 | $20 |
| Metformin Hcl Er | 13 | $54 | $4 |
Year by year
| 2024 | 809 | 198 | 0% (0) | 63% | $491,026 |
| 2023 | 392 | 99 | 0% (0) | 69% | $269,790 |
| 2022 | 155 | 22 | 0% (0) | 68% | $69,006 |
| 2021 | 164 | 23 | 0% (0) | 76% | $82,297 |
| 2020 | 127 | 23 | 0% (0) | 27% | $23,633 |
| 2019 | 215 | 37 | None | 33% | $36,555 |
| 2018 | 382 | 82 | 0% (0) | None | $29,801 |
| 2017 | 65 | 16 | 0% (0) | None | $5,412 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 11 drugs
| Trulicity | 46 | $61,974 | $1,347 |
| Tymlos | 20 | $52,610 | $2,631 |
| Ozempic | 27 | $41,489 | $1,537 |
| Jardiance | 14 | $23,111 | $1,651 |
| Lantus Solostar | 42 | $20,420 | $486 |
| Novolog Flexpen | 18 | $9,988 | $555 |
| Synthroid | 21 | $1,763 | $84 |
| Nano 2nd Gen Pen Needle | 11 | $1,152 | $105 |
| Levothyroxine | 19 | $274 | $14 |
| Metformin | 27 | $170 | $6 |
| Alendronate | 17 | $143 | $8 |
2022: 5 drugs
| Ozempic | 16 | $13,840 | $865 |
| Januvia | 22 | $12,997 | $591 |
| Trulicity | 12 | $11,306 | $942 |
| Metformin Hcl Er | 13 | $191 | $15 |
| Levothyroxine | 11 | $132 | $12 |
2021: 8 drugs
| Trulicity | 32 | $27,345 | $855 |
| Ozempic | 14 | $11,494 | $821 |
| Januvia | 18 | $10,384 | $577 |
| Jardiance | 11 | $8,288 | $753 |
| Tresiba Flextouch U-100 | 11 | $5,411 | $492 |
| Lantus Solostar | 12 | $5,212 | $434 |
| Levothyroxine | 15 | $209 | $14 |
| Metformin Hcl Er | 11 | $96 | $9 |
2018: 9 drugs
| Symbicort | 16 | $5,200 | $325 |
| Ventolin Hfa | 11 | $601 | $55 |
| Atorvastatin | 15 | $152 | $10 |
| Tamsulosin | 11 | $138 | $13 |
| Simvastatin | 11 | $123 | $11 |
| Amlodipine Besylate | 20 | $108 | $5 |
| Gabapentin | 19 | $98 | $5 |
| Alendronate | 12 | $69 | $6 |
| Lisinopril | 17 | $31 | $2 |
Money from drug and device companies
$786 in 2025
| 2025 | 11 | 29 | None | $786 |
| 2024 | 6 | 17 | None | $321 |
| 2023 | 8 | 10 | None | $238 |
| 2019 | 1 | 1 | None | $20 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Madrigal Pharmaceuticals | Rezdiffra | $186 | 6 payments
|
| Novo Nordisk | Rybelsus | $117 | 5 payments
|
| Xeris Pharmaceuticals | Gvoke Hypopen | $103 | 5 payments
|
| Amgen | Tepezza | $96 | 3 payments
|
| Almatica Pharma | Teriparatide | $60 | 2 payments
|
| Abbvie | Synthroid | $53 | 2 payments
|
See all 29 published payments
| Xeris Pharmaceuticals | Meals · 2025-12-17 | Gvoke Hypopen | $22 |
| Madrigal Pharmaceuticals | Meals · 2025-12-09 | Rezdiffra | $34 |
| Amgen | Meals · 2025-11-19 | Evenity | $34 |
| Abbvie | Meals · 2025-10-29 | Synthroid | $27 |
| Madrigal Pharmaceuticals | Meals · 2025-10-27 | Rezdiffra | $35 |
| Almatica Pharma | Meals · 2025-10-22 | Teriparatide | $30 |
| Novo Nordisk | Meals · 2025-10-08 | Rybelsus | $24 |
| Lilly USA | Meals · 2025-10-06 | Mounjaro | $32 |
| Amgen | Meals · 2025-10-01 | Tepezza | $32 |
| Xeris Pharmaceuticals | Meals · 2025-09-29 | Gvoke Hypopen | $15 |
| Almatica Pharma | Meals · 2025-09-24 | Teriparatide | $30 |
| Novo Nordisk | Meals · 2025-09-23 | Rybelsus | $26 |
| Madrigal Pharmaceuticals | Meals · 2025-09-16 | Rezdiffra | $46 |
| Madrigal Pharmaceuticals | Meals · 2025-09-16 | Rezdiffra | $5 |
| Medtronic | Meals · 2025-09-11 | Minimed 780g | $23 |
| Abbvie | Meals · 2025-08-28 | Synthroid | $25 |
| Madrigal Pharmaceuticals | Meals · 2025-08-20 | Rezdiffra | $32 |
| Novartis Pharmaceuticals | Meals · 2025-08-13 | Leqvio | $28 |
| Amgen | Meals · 2025-08-06 | Tepezza | $30 |
| Madrigal Pharmaceuticals | Meals · 2025-07-21 | Rezdiffra | $35 |
| Xeris Pharmaceuticals | Meals · 2025-05-19 | Recorlev | $24 |
| Novo Nordisk | Meals · 2025-05-15 | Rybelsus | $24 |
| Novo Nordisk | Meals · 2025-05-14 | Rybelsus | $19 |
| Xeris Pharmaceuticals | Meals · 2025-05-12 | Gvoke Hypopen | $20 |
| Lilly USA | Meals · 2025-04-30 | Mounjaro | $18 |
| Xeris Pharmaceuticals | Meals · 2025-04-28 | Recorlev | $22 |
| Genentech USA | Meals · 2025-04-16 | Xolair | $27 |
| Novo Nordisk | Meals · 2025-04-07 | Ozempic | $24 |
| Blueprint Medicines | Meals · 2025-02-25 | Ayvakit | $45 |
See earlier years (2024, 2023, 2019)
2024: $321
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $97 | 5 payments
|
| Novo Nordisk | Ozempic | $63 | 3 payments
|
| Alexion Pharmaceuticals | Strensiq | $60 | 2 payments
|
| Radius Health | Tymlos | $50 | 2 payments
|
| Lilly USA | Jardiance | $36 | 2 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $16 | 1 payment
|
2023: $238
| MannKind | Afrezza | $83 | 3 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $31 | 1 payment
|
| Lilly USA | Jardiance | $27 | 1 payment
|
| Xeris Pharmaceuticals | Gvoke Hypopen | $25 | 1 payment
|
| Dexcom | Dexcom G6 Transmitter | $23 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Synjardy | $19 | 1 payment
|
| Amgen | Evenity | $16 | 1 payment
|
| Novo Nordisk | Wegovy | $14 | 1 payment
|
2019: $20
| Novo Nordisk | None | $20 | 1 payment
|
Professional record
- NPI
- 1336672591
- Licence
- CA A167384California A167384: Current · expires 2027-12-31
- Group
- Jiva Health Inc
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RE0101X (207RE0101X)
- Mailing address
- Po Box 276950, Sacramento, CA, 95827
- NPI first listed
- 2017-04-05
- NPI last updated
- 2026-09-14
- NPI record certified
- 2026-09-14
This is when the NPI record was last certified, not a medical board exam.